Trial of Chronic Pain Self-Management in Clinic or Community for Low-Income Hispanics
NCT02906358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111
Last updated 2018-11-05
Summary
The purpose of this study is to conduct a parallel group, randomized trial of a chronic pain self-management program in clinic or community settings to educate and support low-income, Hispanic patients with chronic pain to adopt evidence-based pain self-care behaviors and activities.
Conditions
Interventions
- BEHAVIORAL
-
Community-based pain self-management
- BEHAVIORAL
-
Clinic-based pain self-management
Sponsors & Collaborators
-
The University of Texas at San Antonio
collaborator OTHER -
Bexar County Hospital District DBA University Health System
collaborator OTHER -
San Antonio Public Libraries
collaborator UNKNOWN -
South Central Area Health Education Center
collaborator UNKNOWN -
The University of Texas System Healthcare Safety & Effectiveness Grants Program
collaborator UNKNOWN -
The University of Texas Health Science Center at San Antonio
lead OTHER
Principal Investigators
-
Barbara J Turner, MD · UT Health Science Center at San Antonio
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
More Related Trials
-
Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820 ·Status: COMPLETED ·Phase: PHASE3
-
Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.
NCT01838616 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT00449176 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution of Analgesic Tolerance With Opioids
NCT00275249 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
NCT01240863 ·Status: COMPLETED ·Phase: PHASE3
-
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
NCT03201393 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
NCT01081912 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
NCT02603705 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
NCT01452529 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
NCT00361504 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
NCT00487435 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Function in Men Treated for Pain With Opioids or Placebo
NCT00737737 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers
NCT01530542 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
NCT02716857 ·Status: COMPLETED ·Phase: PHASE3
-
Conversion to Embeda With Rescue Trial
NCT01179191 ·Status: TERMINATED ·Phase: PHASE4
-
Lexington Observational Study of Treatment With Compounded Pain Creams
NCT02195752 ·Status: TERMINATED
-
Trial Applying Policy to Eliminate or Reduce Inappropriate Narcotics in the General-population
NCT03400384 ·Status: COMPLETED ·Phase: NA
-
Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain
NCT00565760 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
NCT00364546 ·Status: COMPLETED ·Phase: PHASE3
-
Patient-Centered Opioid Tapering Study
NCT03303209 ·Status: COMPLETED
-
Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
NCT00290901 ·Status: COMPLETED ·Phase: PHASE4
-
HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain
NCT06931158 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
NCT00472303 ·Status: COMPLETED ·Phase: PHASE3
-
Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)
NCT06268522 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
NCT00983385 ·Status: COMPLETED ·Phase: PHASE3